US OTC legislation passes with corporate carve-out


The US House of Representatives passed radical new over-the-counter derivatives legislation on Friday December 11, including a major carve-out for corporate end users.

The House voted 223 to 202 to pass the Wall Street Reform and Consumer Protection Act, a comprehensive financial reform package introduced to the House Rules Committee by the House Committee on Financial Services on December 2. The House debated more than 36 amendments to the bill, many of which centred on the Over-the-Counter

Only users who have a paid subscription or are part of a corporate subscription are able to print or copy content.

To access these options, along with all other subscription benefits, please contact or view our subscription options here:

You are currently unable to copy this content. Please contact to find out more.

Sorry, our subscription options are not loading right now

Please try again later. Get in touch with our customer services team if this issue persists.

New to View our subscription options

If you already have an account, please sign in here.


Want to know what’s included in our free membership? Click here

This address will be used to create your account

You need to sign in to use this feature. If you don’t have a account, please register for a trial.

Sign in
You are currently on corporate access.

To use this feature you will need an individual account. If you have one already please sign in.

Sign in.

Alternatively you can request an individual account here